RAD23A and hepatocellular carcinoma: In the validation set (160 HCC and 160 NC), as shown in Figs S1c and S2b, anti‐RAD23A showed the highest AUC of 0.685, with a sensitivity of 28.5% and a specificity of 90.0%.